Lemaître L
Service de Radiologie Ouest, Hôpital Huriez, CHR, Lille.
Ann Radiol (Paris). 1992;35(4 Pt 2):303-6.
In an open clinical trial, 100 patients have been injected with ioversol (Optiray 350) during an IVP performed for various indications. This low osmolality contrast medium, which is remarkably hydrophilic, has exhibited a safety of use and image quality which were quite satisfactory.